Physician profile
Timothy Johnson
NPI 1982085247
$1,435.11
in general payments reported to CMS, 2019-2025
26 companies · $18.84 in 2025
The $18.84 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $139 · 2021: $281 · 2022: $125 · 2023: $372 · 2024: $271 · 2025: $18.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $414.39 | 2021-2024 | 4k Cable 8.5m, Olympus |
| Abbvie INC. | $186.02 | 2019-2024 | |
| Boston Scientific Corporation | $109.80 | 2019 | |
| Organon LLC | $82.13 | 2023-2025 | Nexplanon |
| Aspira Women'S Health INC | $75.86 | 2023-2024 | Ova1 |
| Astellas Pharma US INC | $74.56 | 2020-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $55.53 | 2020-2023 | Slynd |
| Hologic Sales and Service, LLC | $47.42 | 2024 | Aptima, Novasure |
| Biogen, INC. | $40.70 | 2024 | Zurzuvae |
| Lupin INC. | $36.45 | 2019 | |
| Glaxosmithkline, LLC. | $33.42 | 2020 | |
| Therapeuticsmd, INC. | $30.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.43 | 2020-2021 | |
| Daiichi Sankyo INC. | $23.95 | 2022 | |
| Channel Medsystems, INC. | $23.11 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $20.71 | 2024 | Summit Doppler |
| Bayer Healthcare Pharmaceuticals INC. | $20.29 | 2022 | |
| Amag Pharmaceuticals, INC. | $20.18 | 2019 | |
| Becton, Dickinson and Company | $20.08 | 2020 | |
| Shield Therapeutics INC | $16.16 | 2024 | |
| Sumitomo Pharma America, INC. | $15.81 | 2024 | Gemtesa |
| Roche Diagnostics Corporation | $15.30 | 2019 | |
| Kci USA, INC. | $14.42 | 2021 | |
| Lilly USA, LLC | $13.20 | 2021 | |
| Ethicon US, LLC | $11.69 | 2021 | |
| Acessa Health INC. | $7.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.